Sessa, C <br/><br/>
Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.  [electronic resource] 

 -  Cancer treatment reports  May 1982 
 - 1233-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0361-5960 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Altretamine--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Cisplatin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy<br/>Triazines--administration & dosage